RT @CircAHA: Aortic valve replacement for aortic stenosis is currently timed primarily on the development of symptoms. However, in patients…
RT @CircAHA: Aortic valve replacement for aortic stenosis is currently timed primarily on the development of symptoms. However, in patients…
Interesting role for #WhyCMR in asymptomatic AS. Waiting for results of the @EVoLVeD_trial. @MarcDweck @ClavelLabo @PPibarot
RT @CircAHA: Aortic valve replacement for aortic stenosis is currently timed primarily on the development of symptoms. However, in patients…
RT @Argenscore: 674 ptes. con EA con TAVI o RVA. Independiente de la intervención: fibrosis miocárdica por RNM fue predictor independiente…
RT @CircAHA: Aortic valve replacement for aortic stenosis is currently timed primarily on the development of symptoms. However, in patients…
RT @CircAHA: Aortic valve replacement for aortic stenosis is currently timed primarily on the development of symptoms. However, in patients…
RT @CircAHA: Aortic valve replacement for aortic stenosis is currently timed primarily on the development of symptoms. However, in patients…
RT @CircAHA: Aortic valve replacement for aortic stenosis is currently timed primarily on the development of symptoms. However, in patients…
RT @CircAHA: Aortic valve replacement for aortic stenosis is currently timed primarily on the development of symptoms. However, in patients…
RT @CircAHA: Aortic valve replacement for aortic stenosis is currently timed primarily on the development of symptoms. However, in patients…
RT @Argenscore: 674 ptes. con EA con TAVI o RVA. Independiente de la intervención: fibrosis miocárdica por RNM fue predictor independiente…
RT @CircAHA: Aortic valve replacement for aortic stenosis is currently timed primarily on the development of symptoms. However, in patients…
RT @CircAHA: Aortic valve replacement for aortic stenosis is currently timed primarily on the development of symptoms. However, in patients…
RT @CircAHA: Aortic valve replacement for aortic stenosis is currently timed primarily on the development of symptoms. However, in patients…
674 ptes. con EA con TAVI o RVA. Independiente de la intervención: fibrosis miocárdica por RNM fue predictor independiente (2 veces más mortalidad total y 3 más mortalidad cardiaca a 3.6 años). Cada 1% de aumento del refuerzo: aumenta 11% mortalidad total.
RT @CircAHA: Aortic valve replacement for aortic stenosis is currently timed primarily on the development of symptoms. However, in patients…
Myocardial Scar and Mortality in Severe Aortic Stenosis | Circulation https://t.co/PTC8tX1DTE
RT @CircAHA: Aortic valve replacement for aortic stenosis is currently timed primarily on the development of symptoms. However, in patients…
RT @CircAHA: Aortic valve replacement for aortic stenosis is currently timed primarily on the development of symptoms. However, in patients…
@EchoFiliale
RT @CircAHA: Aortic valve replacement for aortic stenosis is currently timed primarily on the development of symptoms. However, in patients…
RT @CircAHA: Aortic valve replacement for aortic stenosis is currently timed primarily on the development of symptoms. However, in patients…
RT @CircAHA: Aortic valve replacement for aortic stenosis is currently timed primarily on the development of symptoms. However, in patients…
RT @CircAHA: Aortic valve replacement for aortic stenosis is currently timed primarily on the development of symptoms. However, in patients…
RT @CircAHA: Aortic valve replacement for aortic stenosis is currently timed primarily on the development of symptoms. However, in patients…
RT @CircAHA: Aortic valve replacement for aortic stenosis is currently timed primarily on the development of symptoms. However, in patients…
RT @CircAHA: Aortic valve replacement for aortic stenosis is currently timed primarily on the development of symptoms. However, in patients…
Aortic valve replacement for aortic stenosis is currently timed primarily on the development of symptoms. However, in patients with severe AS, LGE on cMR was independently associated with 2-fold higher late mortality. Learn more: https://t.co/jr4gsOC91S ht
#Myocardial Scar and Mortality in Severe #AorticStenosis | #Circulation https://t.co/IM02mz6Nei
Scar(y) news in aortic valve stenosis. Stay tuned on @CircAHA https://t.co/HWjlq9kA9N
RT @MasriAhmadMD: Excellent new data on the association between LGE and mortality in AS. #WhyCMR https://t.co/wGa6VTEX7v @vass_vassiliou…
@Michel_CorbanMD
RT @MasriAhmadMD: Excellent new data on the association between LGE and mortality in AS. #WhyCMR https://t.co/wGa6VTEX7v @vass_vassiliou…
RT @MasriAhmadMD: Excellent new data on the association between LGE and mortality in AS. #WhyCMR https://t.co/wGa6VTEX7v @vass_vassiliou…
I find the indications of #WhyCMR constantly expanding. I practice in an area of world with mostly elderly folks, so AS is in plenty! 😁The issue is finding spots on the scanner for all these severe AS pts which will challenging. Nonetheless, nice article w
RT @MasriAhmadMD: Excellent new data on the association between LGE and mortality in AS. #WhyCMR https://t.co/wGa6VTEX7v @vass_vassiliou…
#AorticValve #AorticValveReplacement #Myocardial Scar and Mortality in Severe #AorticStenosis: Data from the BSCMR Valve Consortium | Circulation https://t.co/rDALbHMYf8
RT @MasriAhmadMD: Excellent new data on the association between LGE and mortality in AS. #WhyCMR https://t.co/wGa6VTEX7v @vass_vassiliou…
RT @MasriAhmadMD: Excellent new data on the association between LGE and mortality in AS. #WhyCMR https://t.co/wGa6VTEX7v @vass_vassiliou…
RT @MasriAhmadMD: Excellent new data on the association between LGE and mortality in AS. #WhyCMR https://t.co/wGa6VTEX7v @vass_vassiliou…
RT @MasriAhmadMD: Excellent new data on the association between LGE and mortality in AS. #WhyCMR https://t.co/wGa6VTEX7v @vass_vassiliou…
RT @MasriAhmadMD: Excellent new data on the association between LGE and mortality in AS. #WhyCMR https://t.co/wGa6VTEX7v @vass_vassiliou…
RT @MasriAhmadMD: Excellent new data on the association between LGE and mortality in AS. #WhyCMR https://t.co/wGa6VTEX7v @vass_vassiliou…
RT @MasriAhmadMD: Excellent new data on the association between LGE and mortality in AS. #WhyCMR https://t.co/wGa6VTEX7v @vass_vassiliou…
RT @MasriAhmadMD: Excellent new data on the association between LGE and mortality in AS. #WhyCMR https://t.co/wGa6VTEX7v @vass_vassiliou…
RT @MasriAhmadMD: Excellent new data on the association between LGE and mortality in AS. #WhyCMR https://t.co/wGa6VTEX7v @vass_vassiliou…
RT @MasriAhmadMD: Excellent new data on the association between LGE and mortality in AS. #WhyCMR https://t.co/wGa6VTEX7v @vass_vassiliou…
RT @MasriAhmadMD: Excellent new data on the association between LGE and mortality in AS. #WhyCMR https://t.co/wGa6VTEX7v @vass_vassiliou…
RT @ralogon: Myocardial Scar and Mortality in Severe Aortic Stenosis: Data from the BSCMR Valve Consortium | Circulation https://t.co/QWqEU…
RT @MasriAhmadMD: Excellent new data on the association between LGE and mortality in AS. #WhyCMR https://t.co/wGa6VTEX7v @vass_vassiliou…
RT @MasriAhmadMD: Excellent new data on the association between LGE and mortality in AS. #WhyCMR https://t.co/wGa6VTEX7v @vass_vassiliou…
RT @MasriAhmadMD: Excellent new data on the association between LGE and mortality in AS. #WhyCMR https://t.co/wGa6VTEX7v @vass_vassiliou…
Excellent new data on the association between LGE and mortality in AS. #WhyCMR https://t.co/wGa6VTEX7v @vass_vassiliou @MarcDweck https://t.co/95QCz8naED
The need for further predictors and accurate risk stratification in #aorticstenosis
Nice @Anvesha19201080 👍
RT @ralogon: Myocardial Scar and Mortality in Severe Aortic Stenosis: Data from the BSCMR Valve Consortium | Circulation https://t.co/QWqEU…
RT @ralogon: Myocardial Scar and Mortality in Severe Aortic Stenosis: Data from the BSCMR Valve Consortium | Circulation https://t.co/QWqEU…
RT @ralogon: Myocardial Scar and Mortality in Severe Aortic Stenosis: Data from the BSCMR Valve Consortium | Circulation https://t.co/QWqEU…
RT @ralogon: Myocardial Scar and Mortality in Severe Aortic Stenosis: Data from the BSCMR Valve Consortium | Circulation https://t.co/QWqEU…
Interesantísimo estudio. La estenosis aórtica es una enfermedad en la que aún hay mucho camino por recorrer.
RT @ralogon: Myocardial Scar and Mortality in Severe Aortic Stenosis: Data from the BSCMR Valve Consortium | Circulation https://t.co/QWqEU…
Myocardial Scar and Mortality in Severe Aortic Stenosis: Data from the BSCMR Valve Consortium | Circulation https://t.co/QWqEUnhCOz
RT @MarcDweck: Important multi centre study just out on line in Circulation confirming the powerful prognostic power of late gadolinium enh…
RT @MarcDweck: Important multi centre study just out on line in Circulation confirming the powerful prognostic power of late gadolinium enh…
RT @unileedscardio: New article on Myocardial Scar and Mortality in Severe Aortic Stenosis: Data from the BSCMR Valve Consortium. Congrats…
RT @unileedscardio: New article on Myocardial Scar and Mortality in Severe Aortic Stenosis: Data from the BSCMR Valve Consortium. Congrats…
RT @vass_vassiliou: Fibrosis in AS is bad.... collaborative UK study ... https://t.co/lYuD8IR1JQ
RT @Doc_Tiger: Many many congratulations! More evidence for CMR in AS #whyCMR @SCMRorg https://t.co/tcfpqZihsK
Many many congratulations! More evidence for CMR in AS #whyCMR @SCMRorg https://t.co/tcfpqZihsK
RT @unileedscardio: New article on Myocardial Scar and Mortality in Severe Aortic Stenosis: Data from the BSCMR Valve Consortium. Congrats…
Pleased to be a small part of the https://t.co/kdN95y7oLc!! Nice when hard work pays off 😆❤️ https://t.co/JveQnwS6fm
Open Access UCL Research: Myocardial Scar and Mortality in Severe Aortic Stenosis: Data from the BSCMR Valve Consortium https://t.co/XHqevjZNSh
New article on Myocardial Scar and Mortality in Severe Aortic Stenosis: Data from the BSCMR Valve Consortium. Congrats to John Greenwood et al! https://t.co/flfnWtqIim
RT @MarcDweck: Important multi centre study just out on line in Circulation confirming the powerful prognostic power of late gadolinium enh…
RT @MarcDweck: Important multi centre study just out on line in Circulation confirming the powerful prognostic power of late gadolinium enh…
RT @ThomasTreibel: Late gadolinium enhancement is an independent predictor of outcome and doubles mortality hazard in severe Aortic Stenosi…
RT @vass_vassiliou: Fibrosis in AS is bad.... collaborative UK study ... https://t.co/lYuD8IR1JQ
RT @MarcDweck: Important multi centre study just out on line in Circulation confirming the powerful prognostic power of late gadolinium enh…
RT @vass_vassiliou: Fibrosis in AS is bad.... collaborative UK study ... https://t.co/lYuD8IR1JQ
RT @vass_vassiliou: Fibrosis in AS is bad.... collaborative UK study ... https://t.co/lYuD8IR1JQ
RT @vass_vassiliou: Fibrosis in AS is bad.... collaborative UK study ... https://t.co/lYuD8IR1JQ
RT @ThomasTreibel: Late gadolinium enhancement is an independent predictor of outcome and doubles mortality hazard in severe Aortic Stenosi…
RT @ThomasTreibel: Late gadolinium enhancement is an independent predictor of outcome and doubles mortality hazard in severe Aortic Stenosi…
RT @ThomasTreibel: Late gadolinium enhancement is an independent predictor of outcome and doubles mortality hazard in severe Aortic Stenosi…
#Myocardial Scar and #Mortality in Severe #Aortic #Stenosis: Data from the #BSCMR Valve Consortium https://t.co/tiG75DQtWb
RT @ThomasTreibel: Late gadolinium enhancement is an independent predictor of outcome and doubles mortality hazard in severe Aortic Stenosi…
RT @MarcDweck: Important multi centre study just out on line in Circulation confirming the powerful prognostic power of late gadolinium enh…
RT @ThomasTreibel: Late gadolinium enhancement is an independent predictor of outcome and doubles mortality hazard in severe Aortic Stenosi…
RT @MarcDweck: Important multi centre study just out on line in Circulation confirming the powerful prognostic power of late gadolinium enh…
RT @ThomasTreibel: Late gadolinium enhancement is an independent predictor of outcome and doubles mortality hazard in severe Aortic Stenosi…
RT @ThomasTreibel: Late gadolinium enhancement is an independent predictor of outcome and doubles mortality hazard in severe Aortic Stenosi…
RT @MarcDweck: Important multi centre study just out on line in Circulation confirming the powerful prognostic power of late gadolinium enh…
RT @ThomasTreibel: Late gadolinium enhancement is an independent predictor of outcome and doubles mortality hazard in severe Aortic Stenosi…
RT @ThomasTreibel: Late gadolinium enhancement is an independent predictor of outcome and doubles mortality hazard in severe Aortic Stenosi…
RT @ThomasTreibel: Late gadolinium enhancement is an independent predictor of outcome and doubles mortality hazard in severe Aortic Stenosi…
RT @ThomasTreibel: Late gadolinium enhancement is an independent predictor of outcome and doubles mortality hazard in severe Aortic Stenosi…
RT @ThomasTreibel: Late gadolinium enhancement is an independent predictor of outcome and doubles mortality hazard in severe Aortic Stenosi…
RT @MarcDweck: Important multi centre study just out on line in Circulation confirming the powerful prognostic power of late gadolinium enh…